Pharmafile Logo
Pharmafocus logo
Advanced Search

liver

Showing 9 posts of 9 posts found.

shutterstock_273326141

Pfizer and Novartis partner up to develop combo therapies for NASH

October 29, 2018
Research and Development, Sales and Marketing Novartis, Pfizer, liver, nash, pharma

Pfizer and Novartis are set to team up in a non-exclusive partnership aimed at the clinical development of one or …

News
1280px-old_surgical_hospital_drummond_street

Regenerative process could be restored in liver after severe injuries, study shows

August 16, 2018
Research and Development Edinburgh University, liver, mice, research, transplants

Scientists at the University of Edinburgh were able to restore a regenerative response that prevented the need for a liver …

News
768px-lambs_liver

Research unveils new drug targets for more effective treatment of liver disease

August 22, 2017
Manufacturing and Production, Research and Development life sciences, liver, liver cancer, liver disease, pharma, pharmaceuticals

Researchers from KTH The Royal Institute of Technology and Gothenburg University have identified new drug targets in the treatment of …

News
gilead-sciences

Gilead presents data highlighting progress and efficacy in liver and hepatitis C therapies

April 20, 2016
Research and Development, Sales and Marketing Gilead, harvoni, hepatitis, liver, sofosbuvir

Gilead (NASDAQ: GILD) has presented a broad range of results on its current and potential therapeutics at the International Liver …

News
angiochip

Engineers create lab-grown heart and liver tissue for drug testing and discovery

March 10, 2016
Manufacturing and Production, Research and Development 3D, angiochip, artificial heart, drug delivery, innovation, liver, vessels

Researchers at University of Toronto have developed “person-on-a-chip” technology which sees the growing of realistic human tissues outside the body. …

News

Gilead acquires Phenex liver disease drugs

January 7, 2015
Research and Development, Sales and Marketing Farnesoid X Receptor, Gilead, liver, nafld, nash, phenex

Gilead Sciences has acquired Phenex Pharmaceuticals’ development programme for the treatment of serious liver diseases. The US biopharma firm will …

News
Takeda image

GE and Takeda make liver pact

November 13, 2014
Research and Development, Sales and Marketing GE Healthcare, Japan, Takeda, US, liver, nafld, nash

GE Healthcare and Takeda Pharmaceutical have joined forces to develop treatments which target liver conditions including non-alcoholic fatty liver disease …

News
BMS image

BMS claims advance with hepatitis C regimen

November 10, 2014
Research and Development, Sales and Marketing BMS, Gilead, HCV, dcv-trio, hep C, hepatitis C, liver, sovaldi

Bristol-Myers Squibb has reported data for its hepatitis C virus cocktail that it says outperforms even newer all-oral therapies in …

News
Afinitor image

Late-stage failure for Afinitor

August 8, 2013
Research and Development, Sales and Marketing Afinitor, Cancer, Novartis, liver

Novartis’ oncology programme has received a blow with the news that Afinitor has failed to help patients live longer in …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024